Semple Patrick L, Jane John A, Laws Edward R
Division of Neurosurgery, University of Cape Town, Cape Town, South Africa.
Neurosurgery. 2007 Nov;61(5):956-61; discussion 961-2. doi: 10.1227/01.neu.0000303191.57178.2a.
The pathogenesis of pituitary apoplexy and the role of precipitating factors in pituitary apoplexy are poorly understood. Most of the published cases are in the form of case reports. We assessed the presumed precipitating factors in a series of patients treated surgically for pituitary apoplexy and reviewed the contemporary published literature.
Thirty-eight consecutive patients with pituitary apoplexy were treated surgically by the Department of Neurosurgery at the University of Virginia, Charlottesville, VA, between January 1996 and March 2006. Their medical records were retrospectively reviewed. Contemporary published cases from 1990 to 2006 were also reviewed.
Nine patients (24%) were identified as having precipitating factors for pituitary apoplexy. The factors identified were coronary artery surgery (two patients), other major surgery (two patients), pregnancy (two patients), gamma knife irradiation, anticoagulant therapy, and coagulopathy secondary to liver failure. The presentation, histology, and outcome were compared between those patients with a precipitating factor and those in whom none was identified. A review of the published literature showed that coronary artery surgery, pituitary stimulation, and coagulopathy were the most common precipitating factors.
A minority of patients with pituitary apoplexy will have precipitating factors. The majority of patients with precipitating factors will have histopathology showing hemorrhagic infarction or hemorrhage. The most common precipitating factors are pituitary stimulation, surgery, particularly coronary artery surgery, and coagulopathy. Caution in doing endocrine investigation, surgery, or anticoagulation in patients with a known pituitary tumor is advised. Patients with no diagnosed pituitary tumor but with a known precipitating factor who have neuro-ophthalmological deterioration or endocrine failure should undergo prompt magnetic resonance image scans and endocrine investigation and endocrine replacement as indicated.
垂体卒中的发病机制以及促发因素在垂体卒中中的作用目前仍了解甚少。大多数已发表的病例为病例报告形式。我们评估了一系列接受垂体卒中手术治疗患者的推测促发因素,并回顾了当代已发表的文献。
1996年1月至2006年3月期间,弗吉尼亚大学夏洛茨维尔分校神经外科对38例连续性垂体卒中患者进行了手术治疗。对他们的病历进行了回顾性分析。同时也回顾了1990年至2006年当代已发表的病例。
9例患者(24%)被确定存在垂体卒中的促发因素。确定的因素包括冠状动脉手术(2例患者)、其他大手术(2例患者)、妊娠(2例患者)、伽玛刀照射、抗凝治疗以及继发于肝功能衰竭的凝血障碍。对有促发因素的患者和未发现促发因素的患者的临床表现、组织学和结局进行了比较。对已发表文献的回顾表明,冠状动脉手术、垂体刺激和凝血障碍是最常见的促发因素。
少数垂体卒中患者会有促发因素。大多数有促发因素的患者组织病理学表现为出血性梗死或出血。最常见的促发因素是垂体刺激、手术,尤其是冠状动脉手术和凝血障碍。建议对已知患有垂体肿瘤的患者在进行内分泌检查、手术或抗凝时要谨慎。对于未诊断出垂体肿瘤但有已知促发因素且出现神经眼科恶化或内分泌功能衰竭的患者,应根据需要及时进行磁共振成像扫描、内分泌检查和内分泌替代治疗。